The story of Viagra presents a nuanced case for investors in the pharmaceutical sector. While initially a blockbuster success, generating billions, the exclusivity expiration and the subsequent arrival of off-brand https://onlinepharmacy575218.ssnblog.com/40361475/the-little-copyright-and-pharma-a-hazardous-play